Sunscreen products: Rationale for use, formulation development and regulatory considerations

被引:63
|
作者
Geoffrey, Kiriiri [1 ]
Mwangi, A. N. [1 ]
Maru, S. M. [1 ]
机构
[1] Univ Nairobi, Sch Pharm, Dept Pharmaceut & Pharm Practice, POB 19676-00202, Nairobi, Kenya
关键词
Sunscreens; Photoprotection; Ultraviolet rays; UVA; UVB; Sun protection factor (SPF); Water resistance; Minimum erythemal dose (MED); SKIN-CANCER; ULTRAVIOLET-RADIATION; PROTECTION FACTORS; SUN EXPOSURE; LIGHT; PREVENTION; EFFICACY;
D O I
10.1016/j.jsps.2019.08.003
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The association of sunrays with skin damage have been known since medieval times. The description of the electromagnetic spectrum facilitated the identification of the ultraviolet light spectrum as being responsible for skin damage resulting from prolonged skin exposure. Sunscreens have been used since ancient civilizations with various measures to limit exposure to sun exposure being employed. Awareness of the risks associated with sunrays has been increasing in the last century, and as a result, the science, technologies, and formulation have advanced significantly. The use of sunscreen products continues rising as government health agencies seek to contain increasing cases of UV induced melanomas. Recreational sunbathing and artificial tanning have increased the risk for these diseases significantly. This review article sought to expound the scientific basis of sunscreen use, the classification, formulation, quality control and regulation across the different countries around the world. The literature review was conducted on Google scholar, PubMed, SCOPUS, Cochrane, BMJ, SCIELO among others. (C) 2019 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University.
引用
收藏
页码:1009 / 1018
页数:10
相关论文
共 50 条
  • [11] Formulation and development of herbal microsponge sunscreen gel
    Dutta, Disha
    Goyal, Naveen
    Kumar Sharma, Dinesh
    [J]. JOURNAL OF COSMETIC DERMATOLOGY, 2022, 21 (04) : 1675 - 1687
  • [12] Formula Development for Baby Sunscreen Products
    Bao Fang
    An Dong
    Bao Xi Jun
    Guo Fang
    [J]. China Detergent & Cosmetics, 2018, 3 (03) : 75 - 79
  • [13] Sunscreen use: controversies, challenges and regulatory aspects
    Loden, M.
    Beitner, H.
    Gonzalez, H.
    Edstrom, D. W.
    Akerstrom, U.
    Austad, J.
    Buraczewska-Norin, I.
    Matsson, M.
    Wulf, H. C.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2011, 165 (02) : 255 - 262
  • [14] Global regulatory considerations for early stage development of orphan medicinal products
    Parsley, Kathryn
    Lecomte-Farrell, Veronica
    Hannus, Henrik
    Madichie, Elizabeth
    McCormick, James
    [J]. HUMAN GENE THERAPY, 2013, 24 (05) : A31 - A31
  • [15] Considerations in the development of live biotherapeutic products for clinical use
    Ross, Jennifer J.
    Boucher, Philip E.
    Bhattacharyya, Siba P.
    Kopecko, Dennis J.
    Sutkowski, Elizabeth M.
    Rohan, Patricia J.
    Chandler, Donna K. F.
    Vaillancourt, Julienne
    [J]. CURRENT ISSUES IN MOLECULAR BIOLOGY, 2008, 10 : 13 - 16
  • [16] Use of nanoscale materials in commercial sunscreen products
    Cole, Michael F.
    Bergeson, Lynn L.
    Hutton, Carla N.
    [J]. Nanotechnology Law and Business, 2012, 9 (01): : 74 - 86
  • [17] In vitro approaches to antioxidant screening for the development of a sunscreen formulation
    Soares, Bruna dos Santos
    Diniz, Raiane Rosales
    de Paiva, Juliana Patrao
    de Padula, Marcelo
    dos Santos, Elisabete Pereira
    Monteiro, Mariana Sato de Souza de Bustamante
    [J]. BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 59
  • [18] Zeofilters for potentially innovative sunscreen products: formulation, stability and spectroscopic studies
    Fantini, Riccardo
    Argenziano, Monica
    Cavalli, Roberta
    Arletti, Rossella
    Mino, Lorenzo
    [J]. JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY A-CHEMISTRY, 2024, 452
  • [19] U.S. Regulatory Considerations for Development of Live Biotherapeutic Products as Drugs
    Dreher-Lesnick, Sheila M.
    Stibitz, Scott
    Carlson, Paul E., Jr.
    [J]. MICROBIOLOGY SPECTRUM, 2017, 5 (05):
  • [20] Regulatory considerations in the clinical development of vaccines indicated for use during pregnancy
    Roberts, Jeffrey N.
    Gruber, Marion F.
    [J]. VACCINE, 2015, 33 (08) : 966 - 972